Placebo marked PEXSIG

DRUG2 trials

Sponsors

University Hospital Birmingham

Conditions

Cardiac Output, LowHypertrophy, Left VentricularMyocardial Reperfusion Injury

Phase 2

Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery

CompletedNCT00845364

University Hospital BirminghamCardiac Output, Low, Myocardial Reperfusion Injury

Start: 2007-02-28End: 2010-04-30Updated: 2010-05-20

Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy

University Hospital BirminghamCardiac Output, Low, Hypertrophy, Left Ventricular, Myocardial Reperfusion Injury

Start: 2009-10-31End: 2012-12-31Target: 220Updated: 2011-08-11

Related Papers

The effect of perhexiline on myocardial protection during coronary artery surgery: a two-centre, randomized, double-blind, placebo-controlled trial

European Journal of Cardio-Thoracic Surgery2014-06-198 citations